Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869334 · ClinicalTrials.gov registry record · NA
Remediation of Auditory Recognition in Schizophrenia With tDCS
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02869334 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 20 participants.
The verdict
NCT02869334, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.
Interventions
- DEVICE Active Transcranial direct current stimulation (tDCS)
- DEVICE Sham Transcranial direct current stimulation (tDCS)
- BEHAVIORAL Auditory Remediation
- BEHAVIORAL Control computer activities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02869334
The ClinicalTrials.gov registry entry for NCT02869334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Active Transcranial direct current stimulation (tDCS) is the first listed.
NCT02869334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02869334 about?
NCT02869334 is a clinical study titled "Remediation of Auditory Recognition in Schizophrenia With tDCS". The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.
What is the current status of trial NCT02869334?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-06. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT02869334?
The interventions under investigation include: Active Transcranial direct current stimulation (tDCS) (DEVICE), Sham Transcranial direct current stimulation (tDCS) (DEVICE), Auditory Remediation (BEHAVIORAL), Control computer activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT02869334?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.